10
NEWS
Checking blood flow in T2D
Aston University scientists have
discovered a more accurate way of
checking the blood flow in the feet of
patients with Type 2 diabetes. Using
lasers, their findings have resulted in
improved accuracy in detecting tiny
changes in microcirculation - the
smallest vessels within the circulatory
system. Changes in flow at this level
can affect whether tissue lives or
dies. People with Type 2 diabetes can
be at risk of foot amputations due to
circulatory complications caused by
their condition.
The new approach underwent
tests on both healthy volunteers
and pilot clinical trials on diabetes
patients by applying a probe to
their skin. The new method showed
a significant improvement in the
diagnostic accuracy of detection of
microvascular changes in the skin
of the feet in patients with Type 2
diabetes.
Nick Jonas, Dexcom and the Superbowl
Beyond Type 1 co-founder Nick Jonas, who has T1D,
appeared on the Today Show in the US to announce
that Dexcom and Beyond Type 1 have pledged $1m
to help address health inequity and continue the
conversation around access to life-changing CGM
technology. Jonas also revealed his second Super
Bowl ad with Dexcom to promote the new Dexcom
G7 and build awareness of the technology available
to help people with diabetes to live better. To read
more CLICK HERE.
Midlands' lifechanging devices
More than 30,000 patients with Type 1 diabetes across
the UK Midlands now have access to life-changing
continuous glucose monitoring technology, thanks to
cost-effective deals secured for patients and rapidly
rolled out by the NHS.
In the summer of 2022, the NHS announced
patients with Type 1 diabetes would be eligible for
continuous glucose monitors (CGMs) after securing a
deal to ensure they cost a similar price to flash glucose
monitors have been available on the NHS for the past
few years and need the patient to 'scan' the device to
get a reading. However, CGM devices do not need the
patient to 'scan', and instead send glucose readings
continuously to a smartphone app. In line with NICE
guidance, patients will be offered either monitor
depending on their needs following consultation with
their local clinician.
The latest rollout figures show the NHS in England
is going well above and beyond its original Long Term
Plan target from 2019 to ensure 20% of people with
Type 1 diabetes would benefit from flash or continuous
glucose monitors, with over 70% of people with Type 1
diabetes now using these systems.
The Human Trial
New documentary film The Human Trial provides
unprecedented, real-time access to a radical stem cell
treatment can now be watched in the UK.
Driven to find a cure for her own Type 1
diabetes, filmmaker Lisa Hepner and her husband,
cinematographer Guy Mossman, set out to learn why
this disease has not yet been cured. The couple were
given unprecedented, real-time access to a clinical
trial which promises to be the breakthrough that
millions of people on insulin have been waiting for.
The critically acclaimed film can now be watched
in the UK on Apple TV, Amazon Prime, and Vimeo on
Demand.
To view a trailer of the film, CLICK HERE.